secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001213900-24-000980
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics effects 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective 12:01 a.m. ET on Jan 4, 2024; shares begin trading split-adjusted same day.
- Common stock CUSIP changed to 471871202; trading symbol remains JSPR.
- Warrants (JSPRW) adjusted: 10 pre-split warrants exercisable for 1 share at $115.00 exercise price.
- No fractional shares issued; cash in lieu paid based on Jan 3, 2024 closing price.
- Split approved by board on Dec 22, 2023, after stockholder authorization on Dec 15, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/0001213900-24-000980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/ea191024-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-000980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer